Takeda Pharmaceuticals Partners with Wipro
News May 23, 2014
Wipro Ltd. has announced a strategic partnership with Takeda Pharmaceutical Company Ltd., the largest pharmaceutical company in Japan and one of the global leaders of the industry.
This strategic partnership will build advanced value in Takeda's operations by consolidating IT platforms across the organization. As a strategic partner, Wipro will build and maintain an "as-a-service" global platform for Takeda that will drive synergies across its global entities through standardization of IT architecture.
Wipro will be primary provider of IT Infrastructure management services covering Takeda's entities across the world, touching 30,000 users in 16 different languages, operating out of data centers in Asia, Europe and America.
Speaking on the engagement, Sangita Singh, Chief Executive - Healthcare and Life Science Business Unit at Wipro said, "We are thrilled to partner with Takeda in its business transformation journey. Wipro is leveraging its experience in enabling global pharma companies to achieve a leaner & standardized IT workplace and implement newer business models that put patient at the core. We look forward to collaboratively partnering with the Takeda team in enabling this unique platform across its global operations."
"Wipro will deliver the "as-a-service" on demand model, which is redefining the way organizations purchase technology. With our global delivery capabilities, Wipro will drive Takeda's IT infrastructure, consolidating and optimizing resources across the organization," added G K Prasanna, Chief Executive - Global Infrastructure Services & Product Engineering Services.
University of Wisconsin–Madison Professor of Chemistry Shannon Stahl has received the Steenbock Professorship in Chemical Sciences. In addition to advancing the fundamental science in this area, Stahl has been involved in numerous industrial collaborations that have led to practical applications, including target applications relevant to pharmaceutical synthesis.READ MORE